Precigen Deferred Long Term Liab vs Net Debt Analysis
PGEN Stock | USD 1.42 0.02 1.43% |
Precigen financial indicator trend analysis is much more than just breaking down Precigen prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Precigen is a good investment. Please check the relationship between Precigen Deferred Long Term Liab and its Net Debt accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.
Deferred Long Term Liab vs Net Debt
Deferred Long Term Liab vs Net Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Precigen Deferred Long Term Liab account and Net Debt. At this time, the significance of the direction appears to have pay attention.
The correlation between Precigen's Deferred Long Term Liab and Net Debt is -0.76. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Net Debt in the same time period over historical financial statements of Precigen, assuming nothing else is changed. The correlation between historical values of Precigen's Deferred Long Term Liab and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Precigen are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Deferred Long Term Liab i.e., Precigen's Deferred Long Term Liab and Net Debt go up and down completely randomly.
Correlation Coefficient | -0.76 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Most indicators from Precigen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Precigen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.At this time, Precigen's Discontinued Operations is very stable compared to the past year. As of the 4th of May 2024, Sales General And Administrative To Revenue is likely to grow to 1.09, while Selling General Administrative is likely to drop about 38.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 18.9M | 6.8M | 468K | 444.6K | Depreciation And Amortization | 1.3M | 2.5M | 6.7M | 9.4M |
Precigen fundamental ratios Correlations
Click cells to compare fundamentals
Precigen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Precigen fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 455.8M | 314.6M | 359.9M | 216.0M | 151.0M | 143.5M | |
Short Long Term Debt Total | 247.9M | 182.3M | 194.2M | 51.4M | 7.1M | 6.7M | |
Other Current Liab | 73.5M | 31.7M | 22.8M | 30.1M | 19.5M | 29.9M | |
Total Current Liabilities | 122.9M | 42.1M | 34.6M | 78.6M | 23.0M | 21.8M | |
Total Stockholder Equity | 71.7M | 67.2M | 107.3M | 126.3M | 118.5M | 112.6M | |
Property Plant And Equipment Net | 86.2M | 44.3M | 45.2M | 15.4M | 14.2M | 13.5M | |
Current Deferred Revenue | 5.7M | 2.8M | 4.4M | 25K | 509K | 483.6K | |
Net Debt | 182.2M | 130.5M | 151.3M | 46.6M | (481K) | (457.0K) | |
Retained Earnings | (1.7B) | (1.8B) | (1.9B) | (1.9B) | (2.0B) | (1.9B) | |
Accounts Payable | 5.9M | 4.6M | 5.4M | 4.1M | 1.7M | 1.6M | |
Cash | 65.8M | 51.8M | 42.9M | 4.9M | 7.6M | 7.2M | |
Non Current Assets Total | 221.1M | 165.6M | 203.2M | 97.8M | 82.3M | 78.2M | |
Non Currrent Assets Other | (13.9M) | (8.6M) | (14.8M) | (8.5M) | (8.6M) | (8.2M) | |
Cash And Short Term Investments | 75.1M | 100.1M | 115.2M | 56.0M | 62.9M | 93.0M | |
Net Receivables | 26.2M | 20.4M | 21.5M | 13.8M | 1.6M | 1.5M | |
Common Stock Shares Outstanding | 154.1M | 167.1M | 197.8M | 200.4M | 244.5M | 134.9M | |
Short Term Investments | 9.3M | 48.3M | 72.2M | 51.1M | 55.3M | 53.0M | |
Liabilities And Stockholders Equity | 455.8M | 314.6M | 359.9M | 216.0M | 151.0M | 143.5M | |
Non Current Liabilities Total | 261.1M | 205.3M | 217.9M | 11.1M | 18.7M | 17.7M | |
Other Current Assets | 6.4M | 7.2M | 6.7M | 4.8M | 4.3M | 5.7M | |
Other Stockholder Equity | 1.8B | 1.9B | 2.0B | 2.0B | 2.1B | 1.4B | |
Total Liab | 384.1M | 247.4M | 252.5M | 89.7M | 41.6M | 39.6M | |
Total Current Assets | 234.6M | 148.9M | 156.6M | 118.2M | 68.8M | 65.3M | |
Accumulated Other Comprehensive Income | (27.5M) | 4.0M | 203K | (3.5M) | (3.9M) | (4.1M) | |
Short Term Debt | 37.8M | 3.0M | 2.0M | 44.4M | 1.2M | 1.1M | |
Intangible Assets | 68.3M | 65.4M | 54.1M | 44.5M | 40.7M | 78.7M | |
Good Will | 63.8M | 54.4M | 54.1M | 36.9M | 26.6M | 25.3M | |
Net Tangible Assets | (60.4M) | (52.6M) | (915K) | 126.3M | 113.6M | 81.8M | |
Long Term Debt | 211.2M | 186.3M | 171.5M | 182.7M | 210.2M | 107.7M | |
Retained Earnings Total Equity | (1.7B) | (1.8B) | (1.9B) | (1.9B) | (1.7B) | (1.8B) | |
Long Term Debt Total | 211.2M | 186.3M | 171.5M | 182.7M | 210.2M | 107.7M | |
Capital Surpluse | 1.8B | 1.9B | 2.0B | 2.0B | 2.3B | 1.7B | |
Inventory | 16.1M | 11.4M | 13.3M | 287K | 1.0 | 0.95 | |
Deferred Long Term Liab | 7.2M | 2.8M | 2.9M | 2.5M | 2.3M | 2.2M | |
Non Current Liabilities Other | 57.4M | 72.0M | 30.9M | 32.6M | 37.5M | 27.7M | |
Property Plant Equipment | 61.0M | 34.9M | 45.2M | 7.3M | 6.6M | 6.3M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Precigen using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.Note that the Precigen information on this page should be used as a complementary analysis to other Precigen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Precigen Stock analysis
When running Precigen's price analysis, check to measure Precigen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precigen is operating at the current time. Most of Precigen's value examination focuses on studying past and present price action to predict the probability of Precigen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Precigen's price. Additionally, you may evaluate how the addition of Precigen to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Precigen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precigen. If investors know Precigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precigen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.39) | Revenue Per Share 0.025 | Quarterly Revenue Growth (0.30) | Return On Assets (0.30) | Return On Equity (0.78) |
The market value of Precigen is measured differently than its book value, which is the value of Precigen that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.